510(k) Report

510(k) · Cleared

Cleared

Envisu Spectral Domain Ophthalmic Imaging System (Sdois)

K120057510(k) TraditionalCleared May 11, 2012123-day reviewClass II21 CFR 886.1570

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bioptigen, Inc. · HLI Ophthalmoscope, Ac-Powered

Cleared on May 11, 2012 as substantially equivalent to K063343 (Bioptigen, Inc., 2006) after a 123-day review. Its family tree reaches back 4 generations to 2002. 6 later devices descend from it.

Decided
May 11, 2012
Review
123 days
Class
Class II
Product code
HLI
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to K012727 (2002). 6 later devices descend from it, 3 citing it directly.

Descendants, by year cleared 2024: 1 descendant cleared2015: 2 descendants cleared2020: 1 descendant cleared2016: 1 descendant cleared2026: 1 descendant clearedK012727 · Humphrey OCT3 · Carl Zeiss Ophthalmic Systems, Inc. · 2002K030433 · Stratusoct with RNFL Normative Database · Carl Zeiss Meditec, Inc. · 2003 · recalledK033123 · Stratusoct with RNFL & Macula Normative Database · Carl Zeiss Meditec, Inc. · 2004 · recalledK063343 · Bioptigen Spectral Domain Ophthalmic Imaging System · Bioptigen, Inc. · 2006200020052010201520202025
  1. Root · 4 generations backK012727 Humphrey OCT3Carl Zeiss Ophthalmic Systems, Inc. · 2002
  2. 3 generations backK030433 Stratusoct with RNFL Normative DatabaseCarl Zeiss Meditec, Inc. · 2003 · Recalled
  3. 2 generations backK033123 Stratusoct with RNFL & Macula Normative DatabaseCarl Zeiss Meditec, Inc. · 2004 · Recalled
  4. 1 generation backK063343 Bioptigen Spectral Domain Ophthalmic Imaging SystemBioptigen, Inc. · 2006
  5. This deviceK120057 Envisu Spectral Domain Ophthalmic Imaging System (Sdois)Bioptigen, Inc. · 2012
  6. Descendant · cites it directly · 1 of its ownK241163 SPECTRALIS with Flex ModuleHeidelberg Engineering GmbH · 2024
  7. Descendant · cites it directly · 1 of its ownK150722 EnFocus 2300, EnFocus 4400Bioptigen, Inc. · 2015
  8. Descendant · cites it directly · 1 of its ownK142953 OCT-CameraOptomedical Technologies GmbH · 2015 · Recalled
  9. Descendant · 2 generations on · 0 of its ownK253837 SPECTRALIS HRA+OCT and variants; SPECTRALIS with Flex ModuleHeidelberg Engineering GmbH · 2026
  10. Descendant · 2 generations on · 0 of its ownK200516 OCT-Camera ID 21101A3Optomedical Technologies GmbH · 2020

Showing 5 of 6 descendants. See all descendants

Descendants cleared per year

2015: 22016: 12020: 12024: 12026: 1
2015high 2 (2015) · low 0 (2017)2026

Most influential descendants

Showing 5 of 6 · See all
  • K241163SPECTRALIS with Flex ModuleHeidelberg Engineering GmbH · 2024 · cites it directly1descendant
  • K150722EnFocus 2300, EnFocus 4400Bioptigen, Inc. · 2015 · cites it directly1descendant
  • K142953OCT-CameraOptomedical Technologies GmbH · 2015 · cites it directly1descendant
  • K253837SPECTRALIS HRA+OCT and variants; SPECTRALIS with Flex ModuleHeidelberg Engineering GmbH · 2026 · 2 generations on0descendants
  • K200516OCT-Camera ID 21101A3Optomedical Technologies GmbH · 2020 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K012727Humphrey OCT3Carl Zeiss Ophthalmic Systems, Inc.2002—
−3K030433Stratusoct with RNFL Normative DatabaseCarl Zeiss Meditec, Inc.20031
−2K033123Stratusoct with RNFL & Macula Normative DatabaseCarl Zeiss Meditec, Inc.20041
−1K063343Bioptigen Spectral Domain Ophthalmic Imaging SystemBioptigen, Inc.2006—
0 (this device)K120057Envisu Spectral Domain Ophthalmic Imaging System (Sdois)Bioptigen, Inc.2012—
+1K241163SPECTRALIS with Flex ModuleHeidelberg Engineering GmbH2024—
+1K150722EnFocus 2300, EnFocus 4400Bioptigen, Inc.2015—
+1K142953OCT-CameraOptomedical Technologies GmbH20152
+2K253837SPECTRALIS HRA+OCT and variants; SPECTRALIS with Flex ModuleHeidelberg Engineering GmbH2026—
+2K200516OCT-Camera ID 21101A3Optomedical Technologies GmbH2020—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201520
201610
202010
202410
202610
FIG. 1 — Lineage of K120057, 2002–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in HLI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K063343Bioptigen Spectral Domain Ophthalmic Imaging System
Summary page 2
…mography imaging technology and incoherent superluminiscent light emitting diode technology as the predicate S0015. The differences between the 2006 predicate, K063343, and the current subject SDOIS are the following design modifications incorporated to enhance device usability and performan…
Bioptigen, Inc.2006—

Also cleared against K063343: 1 other device →

What descends from it? (6)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K241163SPECTRALIS with Flex ModuleHeidelberg Engineering GmbH20241
K150722EnFocus 2300, EnFocus 4400Bioptigen, Inc.20151
K142953OCT-CameraOptomedical Technologies GmbH20151

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 10 years and passes through 3 companies; a new generation was cleared every 2.6 years on median.
  • 2 of the 4 ancestors have a recall of any class.
  • Of its descendants, K241163 (Heidelberg Engineering GmbH, 2024) has gone furthest, with 1 descendant of its own.
  • 1 other device also cites its predicate K063343.

How does its category compare?

All HLI devices

HLI Ophthalmoscope, Ac-Powered: FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.

FDA decisions per year · HLI

1in 2016

2007: 12010: 22011: 32012: 22013: 22014: 42015: 22016: 1
2007high 4 (2014) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · HLI

112in 2014

2011: 36 days median2014: 112 days median
2007high 112 (2014) · low 36 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · HLI

1in 2021

2008: 12009: 12017: 22021: 1
2007high 2 (2017) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · HLI

2in 2024

2008: 12009: 12013: 12018: 12020: 12022: 12023: 22024: 2
2007high 2 (2023) · low 0 (2007)2025

MAUDE reports naming product code HLI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20080—11
20090—11
20102—00
201133600
20122—00
20132—01
2014411200
20152—00
20161—00
20170—20
20180—01
20190—00
20200—01
20210—10
20220—01
20230—02
20240—02
20250—00
20260—0—

What is it indicated for?

Bioptigen Envisu™ Spectral Domain Ophthalmic Imaging System (Envisu™ SDOIS) is intended to acquire, process, display and save depth-resolved images of ocular tissue microstructure using Spectral Domain Optical Coherence Tomography (SD-OCT). The Envisu™ SDOIS is indicated for use as an aid in the diagnosis of physiologic and pathologic conditions of the eye through non-contact optical imaging. Imaging of the various tissues of the eye is supported through…

Read the full statement (116 words)

Bioptigen Envisu™ Spectral Domain Ophthalmic Imaging System (Envisu™ SDOIS) is intended to acquire, process, display and save depth-resolved images of ocular tissue microstructure using Spectral Domain Optical Coherence Tomography (SD-OCT). The Envisu™ SDOIS is indicated for use as an aid in the diagnosis of physiologic and pathologic conditions of the eye through non-contact optical imaging. Imaging of the various tissues of the eye is supported through the use of interchangeable lenses. It is indicated for use on patient populations from premature and neonatal infants to adult, and is suitable for patients ambulatory or confined. The system is indicated for use in upright or supine imaging, handheld or mounted, and is suited for imaging patients under anesthesia.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K120057: Envisu Spectral Domain Ophthalmic Imaging System (Sdois).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K120057

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026